Profitability Ratios
| Ratio |
Value |
| GP Margin |
52.8% |
| EBIT Margin |
10.3% |
| EBITDA Margin |
14.1% |
| Operating Margin |
10.3% |
| Pretax Margin |
5.2% |
| Cont. Ops Margin |
3.4% |
| Net Margin |
3.4% |
| Bottom Line Margin |
3.4% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
2.14 |
| Quick Ratio |
1.01 |
| Solvency Ratio |
0.077 |
| Cash Ratio |
0.13 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-0.41 |
| Forward PEG |
-0.41 |
| Price/Book |
1.22 |
| Price/Sales |
0.92 |
| Price/FCF |
8.35 |
| Price/Op Cash Flow |
7.38 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.3590 |
| Debt/Equity |
0.8082 |
| Debt/Capital |
0.4470 |
| Long-Term Debt/Capital |
0.4468 |
| Financial Leverage |
2.25 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
3.82 |
| Operating Cash Flow Ratio |
0.542 |
| Operating Cash Flow/Sales |
12.4% |
| Free Cash Flow/Operating Cash Flow |
88.4% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
5.33 |
| Interest Coverage |
4.5399 |
| Short-Term Operating Cash Flow Coverage |
239.73 |
| Operating Cash Flow Coverage |
0.20 |
| Capital Expenditure Coverage |
8.62 |
| Dividend + Capital Expenditure Coverage |
3.83 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
52.5895% |
| Dividend Yield |
1.9639% |
| Dividend Yield % |
1.9639% |
| Dividend Per Share |
0.7973 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
44.29 |
| EPS |
1.516 |
| Debt/Share |
27.9040 |
| Cash/Share |
1.32 |
| Book Value/Share |
33.29 |
| Tangible BV/Share |
-11.47 |
| Equity/Share |
33.29 |
| Operating Cash Flow/Share |
5.500 |
| Capital Expenditure/Share |
0.638 |
| FCF/Share |
4.862 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.662 |
| Earnings Before Tax/EBIT |
0.504 |
| Price/Fair Value |
1.22 |
| Debt/Market Cap |
0.6626 |
| Effective Tax Rate |
33.8% |
| Enterprise Value Multiple |
10.62 |
CNMD - CONMED Corporation